Detailed Result for NCT01291836

NCT ID: NCT01291836
NLM Download Date Description: N/A
Study First Submitted Date: 2011-02-07
Last Update Submitted Date: 2017-08-05
Last Update Submitted Date: 2017-08-05
Result First Submitted Date: 2016-01-05
Disposition First Submitted Date: N/A
Start Month Year: December 2010
Start Date: 2010-12-31
Start Date Type: N/A
Verification Month Year: August 2017
Verification Date: 2017-08-31
Completion Month Year: June 2015
Completion Date: 2015-06-30
Completion Date Type: Actual
Primary Completion Month Year: October 2013
Primary Completion Date: 2013-10-31
Primary Completion Date Type: Actual
Study first Submitted QC Date: 2011-02-08
Study first posted Date: 2011-02-09
Result first Submitted QC Date: 2017-08-05
Result First Posted Date: 2018-02-19
Disposition First Submitted QC Date: N/A
Disposition First Posted Date: N/A
Last Updated Submitted QC Date: 2017-08-05
Last Updated Posted Date: 2018-02-19
Target Duration: N/A
Study Type: Observational
Acronym: AKINESIS
Baseline Population: ED presentation with symptoms of Heart Failure.
Brief Title: Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study
Official Title: Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin (N-GAL) Evaluation of Symptomatic Heart Failure Study (AKINESIS)
Overall Status: Completed
Last Known Status: N/A
Phase: N/A
Enrollment: 930
Enrollment Type: Actual
Source: Alere San Diego
Limitation and Caveats: N/A
Number of Arms: N/A
Number of Groups: N/A
Why Stopped: N/A
Has Expanded Access: N/A
Expanded Access Type Individual: N/A
Expanded Access Type Intermediate: N/A
Expanded Access Type Treatment: N/A
Has DMC: true
Is it FDA Regulated Drug: N/A
Is it FDA Regulated Device: N/A
Is it Unapproved Device: N/A
Is PPSD: N/A
Is US Export: N/A
Is Biospec Retention: Samples Without DNA
Biospec Description: Urine Samples, Plasma Samples
Plan to Share IPD: N/A
Plan to Share IPD Description: N/A
IPD Time Frame: N/A
IPD Access Criteria: N/A
IPD URL: N/A